A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure-Reference-Cited by-同舟云学术

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure

Published:2018-01-11 Issue:3 Volume:104 Page:546-552
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Kawakami Rika¹,Lee Candace Y.W.¹,Scott Christopher²,Bailey Kent R.²,Schirger John A.¹,Chen Horng H.¹,Benike Sherry L.¹,Cannone Valentina¹³,Martin Fernando L.¹,Sangaralingham S. Jeson¹,Ichiki Tomoko¹,Burnett John C.¹

Affiliation:

1. Cardiorenal Research Laboratory, Department of Cardiovascular Medicine, Mayo Clinic; Rochester Minnesota USA

2. Department of Health Science Research; Mayo Clinic; Rochester Minnesota USA

3. Department of Clinical and Experimental Medicine; University of Parma Medical School; Parma Italy

Funder

National Institutes of Health

CTSA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.974/fullpdf

Reference33 articles.

1. Innovative therapeutics: designer natriuretic peptides;Meems;JACC Basic Transl. Sci.,2016

2. Liraglutide and cardiovascular outcomes in type 2 diabetes;Marso;N. Engl. J. Med.,2016

3. Therapeutic applications of the cell-penetrating HIV-1 Tat peptide;Rizzuti;Drug Discov. Today.,2015

4. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial;Teerlink;Lancet,2013

5. Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP;Lisy;J. Am. Coll. Cardiol.,2008

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C-type natriuretic peptide (CNP): The cardiovascular system and beyond;Pharmacology & Therapeutics;2024-10

2. Discovery of small molecule guanylyl cyclase B receptor positive allosteric modulators;PNAS Nexus;2024-05-31

3. Targeting the Natriuretic Peptide System to Improve Outcomes;Journal of the American College of Cardiology;2024-03

4. Sex-stratified genome-wide association and transcriptome-wide Mendelian randomization studies reveal drug targets of heart failure;Cell Reports Medicine;2024-02

5. Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failure;Expert Opinion on Investigational Drugs;2023-12-02